![](/img/cover-not-exists.png)
Myasthenia gravis patients with low plasma IL-6 and IFN-γ benefit from etanercept treatment
Erdem Tüzün, Matthew N. Meriggioli, Julie Rowin, Huan Yang, Premkumar ChristadossVolume:
24
Year:
2005
Language:
english
DOI:
10.1016/j.jaut.2005.01.013
File:
PDF, 195 KB
english, 2005